Literature DB >> 16916608

Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP).

Sandro Pignata1, Ciro Gallo, Bruno Daniele, Silvana Elba, Antonio Giorgio, Gaetano Capuano, Luigi Elio Adinolfi, Ilario De Sio, Francesco Izzo, Fabio Farinati, Carlo Del Naja, Maria Stanzione, Fabiana Castiglione, Giampiero Marone, Oreste Cuomo, Martina Felder, Giovanni Battista Gaeta, Ermelinda De Maio, Massimo Di Maio, Giuseppe Signoriello, Francesco Perrone.   

Abstract

PURPOSE: To describe the characteristics at presentation and the outcome of elderly patients (> or =70 years old) with HCC, a retrospective analysis using a CLIP database was performed. PATIENTS AND METHODS: The database included 650 patients. Chi2-test, logistic and Cox model were applied.
RESULTS: Baseline characteristics and stage were similarly among elderly (n=158) and non-elderly (n=492) patients. More elderly patients did not receive any local treatment (56% versus 38%, p<0.0001). Age and CLIP score were independently predictive of the odds of locoregional treatment. Prognosis was worse for elderly patients with a hazard ratio of death of 1.49 (95% CI 1.20-1.86) at multivariable analysis. The survival difference disappeared when patients were compared within each treatment group, suggesting a close link between undertreatment and shorter survival.
CONCLUSION: Elderly patients with HCC have a worse prognosis compared to non-elderly ones. Such difference seems the consequence of undertreatment.

Entities:  

Mesh:

Year:  2006        PMID: 16916608     DOI: 10.1016/j.critrevonc.2006.01.002

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  17 in total

Review 1.  Management of hepatocellular carcinoma in the elderly.

Authors:  Mauro Borzio; Elena Dionigi; Giancarlo Parisi; Ivana Raguzzi; Rodolfo Sacco
Journal:  World J Hepatol       Date:  2015-06-18

2.  Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.

Authors:  Eli Sapir; Yebin Tao; Matthew J Schipper; Latifa Bazzi; Paula M Novelli; Pauline Devlin; Dawn Owen; Kyle C Cuneo; Theodore S Lawrence; Neehar D Parikh; Mary Feng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-09-14       Impact factor: 7.038

3.  Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma.

Authors:  Matan J Cohen; Allan I Bloom; Orly Barak; Alexander Klimov; Tova Nesher; Daniel Shouval; Izhar Levi; Oren Shibolet
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

4.  Factors associated with the overall survival of elderly patients with hepatocellular carcinoma.

Authors:  Hideki Fujii; Yoshito Itoh; Naoki Ohnishi; Masafumi Sakamoto; Tohru Ohkawara; Yoshihiko Sawa; Koichi Nishida; Yasuo Ohkawara; Kanji Yamaguchi; Masahito Minami; Takeshi Okanoue
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

5.  A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma.

Authors:  Olga N Kozyreva; Dorcas Chi; Jeffrey W Clark; Hejing Wang; Kathy P Theall; David P Ryan; Andrew X Zhu
Journal:  Oncologist       Date:  2011-02-24

6.  Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma.

Authors:  Jue Wang; Fen Wei Wang
Journal:  Int J Surg Oncol       Date:  2010-12-20

Review 7.  Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review.

Authors:  Clark DuMontier; Kah Poh Loh; Paul A Bain; Rebecca A Silliman; Tammy Hshieh; Gregory A Abel; Benjamin Djulbegovic; Jane A Driver; William Dale
Journal:  J Clin Oncol       Date:  2020-04-06       Impact factor: 50.717

Review 8.  Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

Authors:  Puneeta Tandon; Guadalupe Garcia-Tsao
Journal:  Liver Int       Date:  2008-12-24       Impact factor: 5.828

9.  Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.

Authors:  Robert J Wong; Douglas A Corley
Journal:  Dig Dis Sci       Date:  2009-01-01       Impact factor: 3.199

10.  Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years.

Authors:  Yun Jung Kim; Byoung Kuk Jang; Eun Soo Kim; Woo Jin Chung; Kyung Sik Park; Kwang Bum Cho; Jae Seok Hwang
Journal:  J Korean Med Sci       Date:  2012-10-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.